Comprehensive Glycomic Analysis Reveals That Human Serum Albumin Glycation Specifically Affects the Pharmacokinetics and Efficacy of Different Anticoagulant Drugs in Diabetes
Authors:
- 23 January 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 69 (4) , 760-770
Abstract
Long-term hyperglycemia in patients with diabetes leads to human serum albumin (HSA) glycation, which may impair HSA function as a transport protein and affect the therapeutic efficacy of anticoagulants in patients with diabetes. In this study, a novel mass spectrometry approach was developed to reveal the differences in the profiles of HSA glycation sites between patients with diabetes and healthy subjects. K199 was the glycation site most significantly changed in patients with diabetes, contributing to different interactions of glycated HSA and normal HSA with two types of anticoagulant drugs, heparin and warfarin. An in vitro experiment showed that the binding affinity to warfarin became stronger when HSA was glycated, while HSA binding to heparin was not significantly influenced by glycation. A pharmacokinetic study showed a decreased level of free warfarin in the plasma of diabetic rats. A preliminary retrospective clinical study also revealed that there was a statistically significant difference in the anticoagulant efficacy between patients with diabetes and patients without diabetes who had been treated with warfarin. Our work suggests that larger studies are needed to provide additional specific guidance for patients with diabetes when they are administered anticoagulant drugs or drugs for treating other chronic diseases.Keywords
Funding Information
- National Natural Science Foundation of China (81570712, 81670247, 21877072, 91439111)
- Natural Science Outstanding Youth Foundation of Shandong Province (JQ201519)
- Major Science and Technology Innovation Project of Shandong Province (2018CXGC1218)
- Natural Science Foundation of Shandong Province (ZR2019MB014)
- Jinan Clinical Medical Science and Technology Innovation Program (201805055)
This publication has 27 references indexed in Scilit:
- Investigation of Non-Enzymatic Glycosylation of Human Serum Albumin Using Ion Trap-Time of Flight Mass SpectrometryMolecules, 2012
- Human serum albumin: From bench to bedsideMolecular Aspects of Medicine, 2012
- The glycation of albumin: Structural and functional impactsBiochimie, 2011
- Comparison of modification sites formed on human serum albumin at various stages of glycationClinica Chimica Acta, 2011
- Addressing Accuracy and Precision Issues in iTRAQ QuantitationMolecular & Cellular Proteomics, 2010
- Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human PlasmaMolecular & Cellular Proteomics, 2010
- Pharmacogenetics of WarfarinAnnual Review of Medicine, 2010
- Proteomic Profiling of Nonenzymatically Glycated Proteins in Human Plasma and Erythrocyte MembranesJournal of Proteome Research, 2008
- Structural and glycation site changes of albumin in diabetic patient with very high glycated albuminClinica Chimica Acta, 2007
- Crystal Structure Analysis of Warfarin Binding to Human Serum AlbuminJournal of Biological Chemistry, 2001